OZOP ENERGY SOLUTIONS, INC. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarter ended March 31, 2026 ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission file number 000-55976 OZOP ENERGY SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 3841 35-2540672 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Number) (IRS Employer Identification Number) 55 Ronald Reagan Blvd. Warwick , NY 10990 (877) 785-6967 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Securities registered under Section 12(b) of the Act: None Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicated by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. : Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use to the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐ As of May 20, 2026, 4,484,160 shares of common stock of the registrant were outstanding. OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED FINANCIAL STATEMENTS Table of Contents Page Consolidated Balance Sheets as of March 31, 2026, and December 31, 2025 (Unaudited) F-1 Consolidated Statements of Operations for the three months ended March 31, 2026, and 2025 (Unaudited) F-2 Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 2026, and 2025 (Unaudited) F-3 Consolidated Statements of Cash Flows for the three months ended March 31, 2026, and 2025 (Unaudited) F-5 Notes to Consolidated Financial Statements (Unaudited) F-6 2 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED BALANCE SHEETS (Unaudited) March 31, December 31, 2026 2025 ASSETS Current Assets Cash $ 83,779 $ 266,431 Prepaid expenses 43,146 32,058 Accounts receivable 26,777 21,579 Inventory 115,200 117,680 Total Current Assets 268,902 437,748 Operating lease right-of-use asset, net 112,363 161,677 Note receivable, related party 325,000 150,000 Property and equipment, net 7,484 10,709 Other assets 13,408 13,408 TOTAL ASSETS $ 727,157 $ 773,542 LIABILITIES AND STOCKHOLDERS’ DEFICIT Liabilities Current Liabilities Accounts payable and accrued expenses $ 13,678,760 $ 12,854,975 Related party liabilities 376,600 281,600 Convertible notes payable, net of discounts 3,702,593 2,748,505 Current portion of notes payable, net of discounts 18,658,590 18,448,173 Derivative liabilities 2,955,700 4,193,434 Operating lease liability, current portion 56,638 84,644 Deferred liability 529,931 532,425 Liabilities of discontinued operations 1,034,811 1,034,811 Total Current Liabilities 40,993,623 40,178,567 Long Term Liabilities Operating lease liability, net of current portion 80,402 93,728 TOTAL LIABILITIES 41,074,025 40,272,295 COMMITMENTS AND CONTINGENCIES - - Stockholders’ Deficit Preferred stock ( 10,000,000 shares authorized, par value $ 0.001 ) Series C Preferred Stock ( 50,000 shares authorized and 2,500 shares issued and outstanding, par value $ 0.001 ) 3 3 Series D Preferred Stock ( 4,570 shares authorized and 1,334 shares issued and outstanding, par value $ 0.001 ) 1 1 Series E Preferred Stock ( 3,000 shares authorized, - 0 - shares issued and outstanding, par value $ 0.001 ) - - Preferred Stock value - Common stock ( 25,990,000,000 shares authorized, par value $ 0.001 ; 3,786,060 and 2,665,555 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively) * 3,786 2,665 Treasury stock, at cost, 47,500 shares of Series C Preferred Stock and 18,667 shares of Series D Preferred Stock ( 11,249,934 ) ( 11,249,934 ) Common stock to be issued; 128 shares * - - Additional paid in capital * 207,748,950 206,114,473 Accumulated deficit ( 236,064,897 ) ( 233,581,184 ) Total Ozop Energy Solutions, Inc. stockholders’ deficit ( 39,562,091 ) ( 38,713,976 ) Noncontrolling interest ( 784,777 ) ( 784,777 ) TOTAL STOCKHOLDERS’ DEFICIT ( 40,346,868 ) ( 39,498,753 ) TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 727,157 $ 773,542 * Retroactively restated for five thousand-for-one share consolidation on January 21, 2026. The accompanying notes are an integral part of these consolidated financial statements. F- 1 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) 2026 2025 For the Three Months Ended March 31, 2026 2025 Revenue $ 56,053 $ 42,257 Cost of revenue 45,659 32,768 Gross profit 10,394 9,489 Operating expenses: General and administrative, related parties 240,000 240,000 General and administrative, other 431,802 700,318 Total operating expenses 671,802 940,318 Loss from continuing operations ( 661,408 ) ( 930,829 ) Other (income) expenses: Interest expense 1,792,032 738,101 Loss (gain) on change in fair value of derivatives 30,273 ( 111,759 ) Total Other Expenses 1,822,305 626,342 Loss from continuing operations before income taxes ( 2,483,713 ) ( 1,557,171 ) Income tax provision - - Net loss from continuing operations ( 2,483,713 ) ( 1,557,171 ) Discontinued Operations: Income (loss) from discontinued operations, net of tax - - Net loss $ ( 2,483,713 ) $ ( 1,557,171 ) Loss from continuing operations per share of common stock basic and fully diluted* $ ( 0.80 ) $ ( 1.02 ) Income from discontinued operations per share of common stock basic and fully diluted* $ 0.00 $ 0.00 Loss per share basic and fully diluted* $ ( 0.80 ) $ ( 1.02 ) Weighted average shares outstanding basic and diluted* 3,115,063 1,521,801 * Retroactively restated for five thousand-for-one share consolidation on January 21, 2026. The accompanying notes are an integral part of these consolidated financial statements. F- 2 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT FOR THE THREE MONTHS ENDED MARCH 31, 2026 (Unaudited) Shares Amount Shares Amount Shares Amount Shares Amount Stock Capital Deficit Interest (Deficit) Common stock to be issued Series C Preferred Stock Series D Preferred Stock Common Stock Treasury Additional Paid-in Accumulated Noncontrolling Total Stockholders’ Equity Shares Amount Shares Amount Shares Amount Shares Amount Stock Capital Deficit Interest (Deficit) Balances January 1, 2026 128 $ - 2,500 $ 3 1,334 $ 1 2,665,555 $ 2,665 $ ( 11,249,934 ) $ 206,114,473 $ ( 233,581,184 ) $ ( 784,777 ) $ ( 39,498,753 ) Common stock shares issued in round up of reverse stock split - - - - - - 58,309 58 - ( 58 ) - - - Issuance of shares of common stock sold, net of issuance costs of $ 5,654 - - - - - - 439,796 440 - 51,629 - - 52,069 Issuance of common stock for services - - - - - - 300,000 300 - 47,700 - - 48,000 Issuance of common stock for accrued interest and fees - - - - - - 322,400 323 - 21,420 - - 21,743 Reclass of derivative liability to equity - - - - - - - - - 1,513,786 - - 1,513,786 Net loss - - - - - - - - - - ( 2,483,713 ) - ( 2,483,713 ) Balances March 31, 2026 128 $ - 2,500 $ 3 1,334 $ 1 3,786,060 $ 3,786 $ ( 11,249,934 ) $ 207,748,950 $ ( 236,064,897 ) $ ( 784,777 ) $ ( 40,346,868 ) The accompanying notes are an integral part of these consolidated financial statements. F- 3 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT FOR THE THREE MONTHS ENDED MARCH 31, 2025 (Unaudited) Shares* Amount * Shares Amount Shares Amount Shares* Amount * Stock Capital * Deficit Interest (Deficit) Common stock to be issued Series C Preferred Stock Series D Preferred Stock Common Stock Treasury Additional Paid-in Accumulated Noncontrolling Total Stockholders’ Equity Shares* Amount* Shares Amount Shares Amount Shares* Amount* Stock Capital* Deficit Interest (Deficit) Balances January 1, 2025 128 $ - 2,500 $ 3 1,334 $ 1 1,417,204 $ 1,417 $ ( 11,249,934 ) $ 205,397,953 $ ( 224,868,641 ) $ ( 784,777 ) $ ( 31,503,978 ) Balances 128 $ - 2,500 $ 3 1,334 $ 1 1,417,204 $ 1,417 $ ( 11,249,934 ) $ 205,397,953 $ ( 224,868,641 ) $ ( 784,777 ) $ ( 31,503,978 ) Issuance of shares of common stock sold, net of issuance costs of $ 10,552 - - - - - - 226,766 227 - 260,578 - - 260,805 Net loss - - - - - - - - - - ( 1,557,171 ) - ( 1,557,171 ) Balances March 31, 2025 128 $ - 2,500 $ 3 1,334 $ 1 1,643,970 $ 1,644 $ ( 11,249,934 ) $ 205,658,531 $ ( 226,425,812 ) $ ( 784,777 ) $ ( 32,800,344 ) Balances 128 $ - 2,500 $ 3 1,334 $ 1 1,643,970 $ 1,644 $ ( 11,249,934 ) $ 205,658,531 $ ( 226,425,812 ) $ ( 784,777 ) $ ( 32,800,344 ) * Retroactively restated for five thousand-for-one share consolidation on January 21, 2026. The accompanying notes are an integral part of these consolidated financial statements. F- 4 OZOP ENERGY SOLUTIONS, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) 2026 2025 For the Three Months Ended March 31, 2026 2025 Cash flows from operating activities: Net loss from continuing operations $ ( 2,483,713 ) $ ( 1,557,171 ) Net income (loss) from discontinued operations - - Net loss ( 2,483,713 ) ( 1,557,171 ) Adjustments to reconcile net loss to net cash used in operating activities Non-cash interest expense 1,006,782 14,241 Amortization and depreciation 52,539 54,305 Loss (gain) on fair value change of derivatives 30,273 ( 111,759 ) Stock compensation expense 48,000 - Changes in operating assets and liabilities: Accounts receivable ( 5,198 ) 31,895 Inventory 2,480 ( 543 ) Prepaid expenses ( 11,089 ) 7,269 Accounts payable and accrued expenses 849,031 785,580 Related party liabilities 95,000 80,000 Deferred revenue ( 2,494 ) 7,865 Operating lease liabilities ( 41,332 ) ( 39,192 ) Customer deposits - 2,688 Net cash used in continuing operations ( 459,721 ) ( 724,822 ) Net cash used in discontinued operations - - Net cash used in operating activities ( 459,721 ) ( 724,822 ) Cash flows from investing activities: Purchase of office and computer equipment - ( 3,490 ) Loans to a related party in exchange for promissory notes ( 175,000 ) - Net cash used in investing activities ( 175,000 ) ( 3,490 ) Cash flows from financing activities: Proceeds from sale of common stock, net of costs 47,069 260,805 Proceeds from issuances of convertible notes payable, net 215,000 - Proceeds from issuances of notes payable, net 190,000 - Net cash provided by financing activities 452,069 260,805 Net decrease in cash ( 182,652 ) ( 467,507 ) Cash, Beginning of period 266,431 797,139 Cash, End of period $ 83,779 $ 329,632 Supplemental disclosure of cash flow information: Cash paid for interest $ - $ - Cash paid for income taxes $ - $ - Schedule of non-cash Investing or Financing Activity: Common stock issued for accrued interest $ 21,743 $ - Debt discount related to derivative liability $ 222,000 $ - Reclass of derivative liability to equity $ 1,513,786 $ - The accompanying notes are an integral part of these consolidated financial statements. F- 5 OZOP ENERGY SOLUTIONS, INC. Notes to Consolidated Financial Statements March 31, 2026 (Unaudited) NOTE 1 - ORGANIZATION Business Ozop Energy Solutions, Inc. (the” Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. Ozop Energy Systems, Inc. a Nevada corporation and a wholly owned subsidiary of the Company, operates in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. Ozop Engineering and Design Inc. a Nevada corporation and a wholly owned subsidiary of the Company, specializes in lighting commissioning services. EV Insurance Company a Delaware corporation and a wholly owned subsidiary of the Company, DBA as Ozop Plus markets vehicle service contracts (VSC’s”) for EV’s that offer consumers to be able to purchase additional months and miles above the manufacturer’s warranty. Automated Room Controls, Inc, a Nevada corporation and a wholly owned subsidiary of the Company have developed products to be an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. Reverse Stock Split On January 16, 2026, the Company filed a Certificate of Amendment to the Certificate of Incorporation of the Company with the Nevada Secretary of State to effect a reverse stock split at a 1-for-5,000 ratio. On January 21, 2026 (the “Effective Time”), every 5,000 shares of issued and outstanding Common Stock automatically combined into one issued share of common stock, with no change in par value. No fractional shares were issued as a result of the Reverse Stock Split. Instead of issuing fractional shares, the Company rounded shares up or down to the nearest whole number as determined by DTC at the participant level. The Reverse Stock Split did not modify any voting rights or other terms of the Common Stock. The Company’s Common Stock began trading on a reverse stock split-adjusted basis at the open of the markets on February 21, 2026. As a result, the number of shares of Common Stock outstanding was reduced from 13,327,772,635 shares to 2,665,555 shares, exclusive of 58,309 whole shares issued for rounding up fractional shares (which were issued in January 2026), and the number of authorized shares of Common Stock remains 25,990,000,000 shares. Unless otherwise indicated, all issued and outstanding stock and per share amounts contained in the accompanying consolidated financial statements have been adjusted to reflect the 1-for-5,000 Reverse Stock Split for all prior periods presented. Proportionate adjustments were made to the exercise prices and the number of shares underlying outstanding warrants and any convertible instruments, as applicable. The impacts of the Reverse Stock Split were applied retroactively for all periods presented in accordance with applicable guidance, less the number of rounded whole shares issued for fractional shares. Therefore, prior period amounts are different than those previously reported. Certain amounts within the following tables may not foot due to rounding. The following table illustrates changes in equity, as previously reported prior to, and as adjusted subsequent to, the impact of the Reverse Stock Split retroactively adjusted for the periods presented: SCHEDULE OF CHANGES OF EQUITY TO THE IMPACT OF REVERSE STOCK SPLIT As Previously Reported Impact of Reverse Stock Split As Revised March 31, 2025 As Previously Reported Impact of Reverse Stock Split As Revised Common stock - shares 8,219,844,297 ( 8,218,200,327 ) 1,643,970 Common stock - amount $ 8,219,844 $ ( 8,218,200 ) $ 1,644 Common stock to be issued- shares 637,755 ( 637,627 ) 128 Common stock to be issued- amount $ 638 $ ( 638 ) $ - Additional paid-in capital $ 197,439,693 $ 8,218,838 $ 205,658,531 As Previously Reported Impact of Reverse Stock Split As Revised December 31, 2024 As Previously Reported Impact of Reverse Stock Split As Revised Common stock - shares 7,086,021,742 ( 7,084,604,538 ) 1,417,204 Common stock - amount $ 7,086,021 $ ( 7,084,604 ) $ 1,417 Common stock to be issued - shares 637,755 ( 637,627 ) 128 Common stock to be issued - amount $ 638 $ ( 638 ) $ - Additional paid-in capital $ 198,312,711 $ 7,085,242 $ 205,397,953 F- 6 The following table illustrates changes in loss per share and weighted average shares outstanding, as previously reported prior to, and as adjusted subsequent to, the impact of the Reverse Stock Split retroactively adjusted for periods presented: SCHEDULE OF CHANGE IN LOSS PER SHARE AND WEIGHTED AVERAGE SHARES As Previously Reported Impact of Reverse Stock Split As Revised Three Months ended March 31, 2025 As Previously Reported Impact of Reverse Stock Split As Revised Loss attributable to common shareholders $ ( 1,557,171 ) $ — $ ( 1,557,171 ) Weighted average shares used to compute basic and diluted EPS 7,609,003,782 ( 7,607,481,981 ) 1,521,801 Loss from continuing operations per share - basic and diluted $ ( 0.00 ) $ ( 1.02 ) $ ( 1.02 ) Income from discontinued operations per share - basic and diluted $ 0.00 $ - $ 0.00 Loss per share - basic and diluted $ ( 0.00 ) $ ( 1.02 ) $ ( 1.02 ) The following shares of common stock exercisable or issuable from outstanding stock warrants and convertible instruments were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive: SCHEDULE OF COMMON STOCK EXERCISABLE OR ISSUABLE FROM OUTSTANDING STOCK WARRANTS As Previously Reported Impact of Reverse Stock Split As Revised March 31, 2025 As Previously Reported Impact of Reverse Stock Split As Revised Unexercised common stock purchase warrants 732,024,518 ( 731,878,113 ) 146,405 Convertible preferred stock 12,329,766,446 ( 12,327,300,493 ) 2,465,953 Convertible notes payable 471,429,292 ( 471,335,006 ) 94,286 Promissory notes payable 7,577,465,753 ( 7,575,950,260 ) 1,515,493 NOTE 2 – GOING CONCERN AND MANAGEMENT’S PLANS The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2026, the Company had an accumulated deficit of $ 236,064,897 and a working capital deficit of $ 40,724,721 . As of March 31, 2026, the Company was in default of $ 18,714,423 plus accrued interest on debt instruments due to non-payment upon maturity dates or failure to comply with the loan’s contractual payment terms. Current cash balances are not sufficient to satisfy obligations currently due. Management is exploring capital raising options which may or may not become available on a timely basis to meet the obligations that are past due. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern. Management’s Plans As a public company, Management believes it will be able to access the public equities market for fund raising for product development, sales and marketing and inventory requirements as we expand our distribution in the U.S. market. During the three months ended March 31, 2026, the Company received $ 190,000 in new promissory notes, and $ 215,000 in convertible notes. Subsequent to March 31, 2026, the Company received $ 100,000 in exchange for a promissory note of $ 110,000 and received $ 93,000 in exchange for a convertible promissory note of $ 100,000 . F- 7 On April 11, 2025, the Company entered into an Equity Financing Agreement (the “2025 Financing Agreement”) and Registration Rights Agreement (the “2025 Registration Rights Agreement”) with GHS. Under the terms of the Financing Agreement, GHS has agreed to provide the Company with up to $ 10,000,000 (the “Commitment Amount”) of funding upon effectiveness of a registration statement on Form S-1. Pursuant to the effectiveness of the registration statement the Company has the right to deliver puts to GHS and GHS will be obligated to purchase shares of our common stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice will not exceed three hundred percent (300%) of the average of the daily trading dollar volume of the Company’s common stock during the ten (10) trading days preceding the put, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the 2025 Financing Agreement, GHS and its affiliates will not be permitted to purchase, and the Company may not put shares of the Company’s common stock to GHS that would result in GHS’s beneficial ownership equalling more than 4.99% of the Company’s outstanding common stock. The price of each put share shall be equal to eighty percent (80%) of the lowest daily volume weighted average price of the Company’s common stock for the ten (10) consecutive trading days preceding the date on which the applicable put iso GHS. No put will be made in an amount equalling less than $10,000 or greater than $1,000,000. Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the registration statement on Form S-1 or the date on which GHS has purchased an aggregate of $10,000,000 worth of put shares. The Company also agreed to issue to the investor as an equity incentive shares (the “Commitment Shares”) equal to one quarter of one percent (0.25%) of the Commitment Amount, priced at a fixed price equalling ninety-five (95%) of the VWAP for the trading day preceding the execution of Agreements. This equates to $25,000, and as of the filing date of this quarterly report the shares have not been issued. On May 7, 2025, the Company receive a Notice of Effectiveness for the sale of up to 800,000 post reverse split ( 4,000,000,000 prior to the reverse split) shares of the Company’s common stock to GHS, pursuant to the April 11, 2025, Financing Agreement and Registration Rights Agreement. For the three months ended March 31, 2026, the Company sold to GHS 439,796 post reverse split shares of common stock for proceeds of $ 47,069 net of offering costs and $ 5,000 of note payables paid. Ozop Energy Systems OES operates in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution. Equipment Distributor: In April 2021, the Company signed a five-year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company’s lease obligations through May 31, 2026, the lease termination date. Modular Energy Distribution System: The NeoVolt ™ System comprises the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. Our NeoVolt TM System offers (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint. The Company has developed a business plan for NeoVolt™, a scalable battery storage solution that aims to relieve the stress on existing grid infrastructure by providing distributed energy storage. With the first stage of engineered technical drawings completed, we are advancing to stage two and preparing to construct the initial prototype or proof of concept (PoC). NeoVolt™ is designed with advanced features, including automatic adoption of connected devices and dynamic load balancing through a master-slave configuration. These capabilities enable NeoVolt™ to seamlessly integrate with and manage energy flows across multiple devices. Furthermore, the PoC is contingent upon recent advancements in EV charging and discharging standardizations, including on-board inverters and bi-directional capabilities, to ensure compatibility and efficiency in both residential and commercial applications. OZOP Plus Ozop Plus markets vehicle service contracts (VSC’s”) for electric vehicles (EV’s) that offer consumers to be able to purchase additional months and miles above the manufacturer’s warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. EVCO has agreements with others whereby the battery premium associated with any EV VSC will be ceded to EVCO. OZOP Plus markets vehicle service contracts (“VSC’s”) for electric vehicles (EV’s) that offer consumers to be able to purchase additional months and miles above the manufacturer’s warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners’ concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the OZOP Plus marketed VSC’s will give “peace of mind” to the EV buyer. On October 23, 2024, Ozop Capital Partners, Inc. entered into an agreement with Empire Auto Protect (“Empire”). Under the agreement, Empire will white label Royal Administration’s Fully Charged VSC, to be marketed as Empire Plus. OZOP Plus will be ceded the battery premium portion of all of the Empire Plus VSC’s contracted. F- 8 Ozop Engineering and Design OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED provides its’ customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs by working with architects, engineers, facility managers, electrical contractors and engineers. OED specializes in lighting commissioning services. On September 27, 2024, OED signed an agreement with Leviton Manufacturing Co, Inc., to serve as a field service technician for their advanced lighting control systems. Automated Room Controls (ARC) ARC is developing products to be an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. At its core, it employs a hybrid network topology that facilitates both resilient wired connections and flexible wireless communications, making it suitable for complex infrastructural environments. The system is equipped with an array of sensors and control nodes, enabling precise light management and energy usage monitoring. With support for protocols such as DALI and Zigbee, alongside the capability for seamless integration with IoT platforms, ARC offers a comprehensive solution for intricate lighting networks. This system is designed not just for control and efficiency, but also for adaptability to diverse architectural and electrical layouts, embodying a technical solution for advanced, energy-conscious lighting management. NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2026, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2026, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2025, included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on May 14, 2026. Certain reclassifications have been made to previously reported amounts to be consistent with the current year period. The unaudited consolidated financial statements include the accounts of the Company and the Company’s wholly owned subsidiaries Ozop Energy Systems, Inc. (“OES”), Ozop Capital Partners, Inc. (“Ozop Capital”), Ozop Engineering and Design, Inc. (“OED), Automated Room Controls, Inc. (“ARC”), Power Conversion Technologies, Inc. (“PCTI”), Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”). All intercompany accounts and transactions have been eliminated in consolidation. F- 9 Cash and Cash Equivalents The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash is maintained at a major financial institution. Accounts held at U.S. financial institutions are insured by the FDIC up to $ 250,000 . The Company is exposed to credit risk in the event of default by the financial institutions or the issuers of these investments to the extent the amounts on deposit or invested are in excess of amounts that are insured. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at March 31, 2026, and December 31, 2025, and there was no excess of the FDIC insurance as of March 31, 2026, and December 31, 2025. The Company has not experienced any losses on these accounts and management believes, based upon the quality of this major financial institution, that the credit risk with regard to these deposits is not significant. Sales Concentration and credit risk Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2026, and 2025, and their accounts receivable balance as of March 31, 2026: SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR Sales % Three Months Ended March 31, 2026 Sales % Three Months Ended March 31, 2025 Accounts receivable balance March 31, 2026 Customer A 96 % 44 % $ 18,715 Customer B - % 28 % $ - Customer C - % 20 % $ - Accounts Receivable The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience. As of March 31, 2026, two customers represented 70 %, and 22 %, respectively of our outstanding accounts receivable. As of December 31, 2025, two customers represented approximately 66 % and 28 %, respectively of our outstanding accounts receivable. Inventory Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs consist of finished goods. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. Finished goods inventories as of March 31, 2026, and December 31, 2025, were $ 115,200 and $ 117,680 , respectively. There are no inventory markdowns for the three months ended March 31, 2026, and 2025. Purchase concentration ARC began purchasing inventory during the three months ended March 31, 2025. For the three months ended March 31, 2026, ARC made no purchases. OES purchases finished renewable energy products from its’ suppliers. For the three months ended March 31, 2026, and 2025, OES made no purchases. F- 10 Revenue Recognition The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products or providing services by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms for product sales or upon delivery of service to the customer for installation services. Any advance payments are recorded as current liability until revenue is recognized. For product sales contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges. For installation services contracts with customers, the Company invoices the customer upon completion of the job and recognizes revenue based on the invoiced amount. The following table disaggregates our revenue by major source for the three months ended March 31, 2026, and 2025: SCHEDULE OF DISAGGREGATION OF REVENUE 2026 2025 Three months ended March 31, 2026 2025 Sourced and distributed products $ 315 $ 3,024 OED Installations 55,738 39,233 Total $ 56,053 $ 42,257 Advertising and Marketing Expenses The Company expenses advertising and marketing costs (including trade shows) as incurred. For the three months ended March 31, 2026, and 2025, the Company recorded advertising and marketing expenses of $ 2,487 and $ 27,740 , respectively. Research and Development Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the three months ended March 31, 2026, and 2025, the Company recorded $ 142 and $ 24,668 of research and development expenses, respectively. Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. F- 11 The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized using the effective interest method. The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the conversion method with immediate expense of unamortized discount. Upon conversion, the remaining unamortized discount on the debt host (the conversion portion) is immediately recognized in earnings, and the carrying amounts of the debt host and the bifurcated conversion option liability (measured at fair value on the conversion date) is derecognized, and equity is recognized for the same amount, with no additional gain or loss recognized in earnings upon conversion. Distinguishing Liabilities from Equity The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity , to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares. Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity. Our CEO and Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company. F- 12 Initial Measurement The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received. Subsequent Measurement – Financial Instruments Classified as Liabilities The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in the fair value of its financial instruments classified as liabilities are recorded as other income (expenses). Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. From time to time, certain of the Company’s embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses and certain notes payable approximate their fair values because of the short maturity of these instruments. The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2026, and December 31, 2025, for each fair value hierarchy level: SCHEDULE OF DERIVATIVE INSTRUMENTS March 31, 2026 Derivative Liabilities Total Level I $ - $ - Level II $ - $ - Level III $ 2,955,700 $ 2,955,700 December 31, 2025 Derivative Liabilities Total Level I $ - $ - Level II $ - $ - Level III $ 4,193,434 $ 4,193,434 F- 13 Earnings (Loss) Per Share The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of March 31, 2026, and 2025, the Company’s dilutive securities are convertible into approximately 91,496,943 and 4,222,137 post reverse split ( 21,110,686,009 , prior to the reverse split) shares of common stock, respectively. The following table represents the classes of dilutive securities as of March 31, 2026, and 2025, as restated for the 1:5,000 reverse stock split: SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE March 31, 2026 March 31, 2025 Convertible preferred stock (1) 5,679,090 2,465,953 Unexercised common stock purchase warrants (1) 1,271,405 146,405 Convertible notes payable (1) 76,482,377 94,286 Promissory notes payable (1) 8,064,071 1,515,493 Total 91,496,943 4,222,137 (1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99 % of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position. F- 14 Recently adopted accounting pronouncements Financial Instruments – Measurement of Credit Losses for Accounts Receivable and Contract Assets In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts receivable and contract assets. This update is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date. Early adoption is permitted. We adopted this ASU on a prospective basis effective January 1, 2026 and the adoption did not have a material impact on our consolidated financial statements. Recently issued accounting pronouncements not yet adopted Disaggregation of Income Statement Expenses In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, which requires disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 requires new financial statement disclosures in tabular format, disaggregating information about prescribed categories underlying any relevant income statement expense caption. The prescribed categories include, among other things, purchases of inventory, employee compensation, depreciation, and intangible asset amortization. Additionally, entities must disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and for interim reporting periods within fiscal years beginning after December 15, 2027. The guidance can be applied prospectively with an option for retrospective application. Early adoption is also permitted. We are currently evaluating the provisions of this ASU. Interim Reporting: Narrow-Scope Improvements. In December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements. Codification Improvements In December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements. F- 15 NOTE 4 – PROPERTY AND EQUIPMENT The following table summarizes the Company’s property and equipment: SCHEDULE OF PROPERTY AND EQUIPMENT March 31, 2026 December 31, 2025 Office equipment $ 239,336 $ 239,336 Less: Accumulated depreciation ( 231,852 ) ( 228,627 ) Property and Equipment, Net $ 7,484 $ 10,709 Depreciation expense was $ 3,225 and $ 16,091 for the three months ended March 31, 2026, and 2025, respectively. NOTE 5 - CONVERTIBLE NOTES PAYABLE AND DERIVATIVE LIABILITIES Convertible Promissory Notes are categorized as equity or debt based on the terms of the notes and the guidance in ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging. Convertible notes that meet the criteria for equity classification (e.g., conversion into a fixed number of shares with no obligation to deliver cash) are recorded in equity at issuance. Instruments classified as equity are not subsequently remeasured, and no interest expense is recognized. Convertible notes that include a contractual obligation to deliver cash or other financial assets, or that do not meet the criteria for equity classification, are recorded as debt. These notes are initially recognized at the proceeds received, net of discounts and issuance costs in accordance with ASC 480-10-55-44 on the consolidated balance sheets, and subsequently measured at amortized cost using the effective interest method. Interest expense is recognized in the statement of operations. If the instrument contains embedded conversion features or other terms that require bifurcation under ASC 815, these features are separated from the host contract and recorded as derivative liabilities at fair value. Derivative liabilities are remeasured at fair value at each reporting date, with changes in fair value recognized in the consolidated statements of operations. The Company accounts for derivative financial instruments in accordance with Accounting Standards Codification (ASC) 815, Derivatives and Hedging. Under this guidance, the Company evaluates whether an embedded feature within a financial instrument is required to be accounted for separately as a derivative. Embedded derivatives that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that are not eligible for the scope exceptions under ASC 815, are bifurcated from the host instrument and accounted for as separate derivative financial instruments. These derivatives are recognized as either assets or liabilities on the balance sheet and are measured at fair value, with changes in fair value recognized in the consolidated statements of operations in the period in which they occur. When the Company issues convertible debt instruments that contain embedded conversion features with variable settlement terms or other features that result in a potential issuance of a variable number of shares, the embedded conversion feature is assessed under ASC 815 -15-25 and ASC 815-10-15-83. If the conversion feature requires bifurcation, it is separated from the debt host and accounted for as a derivative liability. On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a past-due 15 % convertible note issued by the Company on September 13, 2017. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 25,000 . F- 16 On May 28, 2025 (the “Issue Date”), the Company entered into a 12 %, $ 200,000 face value promissory note (the “May 2025 Note”), with a third-party (the “Holder”) due May 28, 2026 (the “Maturity Date”). The Holder shall have the right from time to time, and at any time following, convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company. The per share conversion price into which Principal Amount and interest (including any Default Interest) under this Note shall be convertible into shares of Common Stock hereunder as further described in this Note (the “Conversion Price”) shall equal the Market Price (as defined in the Note), subject to adjustment as provided in this Note. “Market Price” shall mean 70% of the lowest Trading Price (as defined below) for the Common Stock during the five (5) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. “Trading Price” means, for any security as of any date, the volume weighted average price on the Principal Market as reported by a reliable reporting service (“Reporting Service”) designated by the Holder (i.e. Quotestream or Bloomberg). The Company received proceeds of $ 191,000 on June 3, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 9,000 . Pursuant to ASC 815, the Company determined that the conversion feature is embedded in the debt host and accounted for the conversion feature as a derivative liability with an initial fair value of $ 179,173 by the Monte Carlo simulation valuation method (with assumptions of volatility of 236.61 % and risk free rate of 4.16 %). In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 200,000 post reverse split ( 1,000,000,000 prior to the reverse split) shares of common stock at an exercise price of $ 1.00 post reverse split ($ 0.0002 prior to the reverse split) per share, subject to adjustments and expires on the five-year anniversary of the Issue Date. At issuance, the Company had insufficient authorized shares available to settle these outstanding warrants, and these warrants were initially classified and recorded as a derivative liability. The warrants were valued at $ 969,039 at issuance, by the Monte Carlo simulation valuation method (with assumptions of volatility of 187.76 % and risk free rate of 4.05 %). The derivative liabilities from the embedded conversion feature and liability-classified warrants resulted in a debt discount of $ 191,000 , and a derivative expense of $ 957,212 at issuance. For the three months ended March 31, 2026, amortization of the debt discount (including debt issuance costs) of $ 64,491 based on the effective interest method was charged to interest expense. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of the convertible note was $ 200,000 , with a carrying value of $ 97,017 , and $ 32,526 net of unamortized discounts of $ 102,983 and $ 167,474 , as of March 31, 2026, and December 31, 2025, respectively. As of November 28, 2025, the Company was in default of this note due to violation of the “Amortization Payments” term as specified in the note agreement, which requires the Company to make monthly repayment instalment of $ 37,300 over a six-month period starting from November 28, 2025, and repay all remaining outstanding amounts under this note on May 28, 2026, the Maturity Date. On July 15, 2025 (the “Issue Date”), the Company entered into a 12 %, $ 200,000 face value promissory note (the “July 2025 Note”) with a third-party (the “Holder”) due July 14, 2026 (the “Maturity Date”). The July 2025 Note is with the same lender and the same terms as the May 2025 Note. The Company received proceeds of $ 191,000 on July 15, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 9,000 . Pursuant to ASC 815, the Company determined that the conversion feature is embedded in the debt host and accounted for the conversion feature as a derivative liability with an initial fair value of $ 187,309 by the Monte Carlo simulation valuation method (with assumptions of volatility of 257.88 % and risk free rate of 4.11 %). In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 200,000 post reverse split ( 1,000,000,000 prior to the reverse split) shares of common stock at an exercise price of $ 1.00 post reverse split ($ 0.0002 prior to the reverse split) per share, subject to adjustments and expires on the five-year anniversary of the Issue Date. At issuance, the Company had insufficient authorized shares available to settle these outstanding warrants, these warrants are classified and recorded as a derivative liability. The warrants were valued at $ 836,069 at issuance, by the Monte Carlo simulation valuation method (with assumptions of volatility of 185.97 % and risk free rate of 4.05 %). The derivative liabilities from the embedded conversion feature and liability-classified warrants resulted in a debt discount of $ 191,000 , and a derivative expense of $ 832,378 at issuance. For the three months ended March 31, 2026, amortization of the debt discount (including debt issuance costs) of $ 39,885 based on the effective interest method was charged to interest expense. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of the convertible note was $ 200,000 , with a carrying value of $ 75,699 , and $ 35,814 , respectively, net of unamortized discounts of $ 124,301 and $ 164,186 as of March 31, 2026, and December 31, 2025. The Company was in default of this note due to the cross default provisions in this note in connection with default of the May 28, 2025, note. On September 24, 2025 (the “Issue Date”), the Company entered into a 12 %, $ 200,000 face value promissory note (the “September 2025 Note”) with a third-party (the “Holder”) due September 23, 2026 (the “Maturity Date”). The September 2025 Note is with the same lender and the same terms as the May 2025 Note. The Company received proceeds of $ 191,000 on September 24, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 9,000 . Pursuant to ASC 815, the Company determined that the conversion feature is embedded in the debt host and accounted for the conversion feature as a derivative liability with an initial fair value of $ 176,598 by the Monte Carlo simulation valuation method (with assumptions of volatility of 212.92 % and risk free rate of 3.63 %). In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 200,000 post reverse split ( 1,000,000,000 prior to the reverse split) shares of common stock at an exercise price of $ 1.00 post reverse split ($ 0.0002 prior to the reverse split) per share, subject to adjustments and expires on the five-year anniversary of the Issue Date. At issuance, the Company had insufficient authorized shares available to settle these outstanding warrants, these warrants are classified and recorded as a derivative liability. The warrants were valued at $ 332,395 at issuance, by the Monte Carlo simulation valuation method (with assumptions of volatility of 259.75 % and risk free rate of 3.70 %). The derivative liabilities from the embedded conversion feature and liability-classified warrants resulted in a debt discount of $ 191,000 , and a derivative expense of $ 317,993 at issuance. For the three months ended March 31, 2026, amortization of the debt discount (including debt issuance costs) of $ 18,420 based on the effective interest method was charged to interest expense. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of the convertible note was $ 200,000 , with a carrying value of $ 29,994 , and $ 11,574 , respectively, net of unamortized discounts of $ 170,006 and $ 188,426 , as of March 31, 2026, and December 31, 2025, respectively. The Company was in default of this note due to the cross default provisions in this note in connection with the default of the May 28, 2025, note. F- 17 On July 31, 2025, the Company entered into an Exchange Agreement, whereby, the Company agreed that the holder may exchange any part or all of the outstanding principal and interest (the Exchange Amount) of the promissory note entered into on February 9, 2021 at any time and from time to time into the number of common shares equal to the Exchange Amount divided by the lowest trading price from the previous ten (10) trading days, and to extend the maturity date of the note to March 31, 2026. The Company determined the Exchange Agreement represented a substantial modification to the existing debt. Accordingly, the Company extinguished the promissory note dated February 9, 2021, as well as the accrued interest as of July 31, 2025, and recorded two convertible notes, one for the principal amount of $ 2,200,000 with an annual interest rate of 15 % and one for the accrued interest of $ 1,358,229 with no additional interest in the future. The embedded conversion features for these convertible notes were accounted for as derivatives, which were valued at an initial amount of $ 1,842,831 on July 31, 2025 by the Monte Carlo simulation valuation method (with assumptions of volatility of 321 % and risk free rate of 4.24 %), and were recorded as debt discount that will be amortized based on the effective interest method through the new maturity date of the note of March 31, 2026 . For the three months ended March 31, 2026, amortization of the debt discount of $ 814,637 based on the effective interest method was charged to interest expense. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of the two convertible notes was $ 3,458,229 , with a carrying value of $ 3,458,229 as of Mach 31, 2026, and $ 2,643,592 , respectively, net of unamortized discount of $ 814,637 as of December 31, 2025. On January 22, 2026 (the “Issue Date”), the Company entered into a 12 %, $ 147,000 face value promissory note (the “January 2026 Note”) with a third-party (the “Holder”) due October 30, 2026 (the “Maturity Date”). The Company received proceeds of $ 140,000 on January 22, 2026, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 7,000 . Pursuant to ASC 815, the Company determined that the conversion feature is embedded in the debt host and accounted for the conversion feature as a derivative liability with an initial fair value of $ 162,818 by the Monte Carlo simulation valuation method (with assumptions of volatility of 191.43 % and risk free rate of 3.57 % resulted in a debt discount of $ 140,000 , and an expense of $ 22,818 at issuance recognized in the consolidated statements of operations. For the three months ended March 31, 2026, amortization of the debt discount (including debt issuance costs) of $ 11,569 based on the effective interest method was charged to interest expense. As of March 31, 2026, the outstanding principal balance of the convertible note was $ 147,000 , with a carrying value of $ 11,569 , net of unamortized discounts of $ 135,431 as of March 31, 2026. On January 22, 2026 (the “Issue Date”), the Company entered into a 12 %, $ 75,000 face value promissory note (the “2 nd January 2026 Note”) with a third-party (the “Holder”) due October 30, 2026 (the “Maturity Date”). The Company received proceeds of $ 75,000 on January 22, 2026. Pursuant to ASC 815, the Company determined that the conversion feature is embedded in the debt host and accounted for the conversion feature as a derivative liability with an initial fair value of $ 82,961 by the Monte Carlo simulation valuation method (with assumptions of volatility of 191.43 % and risk free rate of 3.57 % resulted in a debt discount of $ 75,000 , and an expense of $ 7,961 at issuance recognized in the consolidated statements of operations. For the three months ended March 31, 2026, amortization of the debt discount of $ 5,085 based on the effective interest method was charged to interest expense. As of March 31, 2026, the outstanding principal balance of the convertible note was $ 75,000 , with a carrying value of $ 5,085 , net of unamortized discounts of $ 69,915 as of March 31, 2026. F- 18 The following table summarizes the Company’s convertible notes payable: SCHEDULE OF CONVERTIBLE NOTES PAYABLE Three Months ended March 31, 2026 Year ended December 31, 2025 Beginning convertible notes principal balance $ 4,083,229 $ 25,000 New convertible note issuances 222,000 600,000 Convertible notes issued in exchange for promissory note and accrued interest as a result of loan modification - 3,558,229 Less: conversion - ( 100,000 ) Less: unamortized discounts ( 602,636 ) ( 1,334,724 ) Ending balance, net of discounts $ 3,702,593 $ 2,748,505 The Company valued the derivative liabilities at March 31, 2026, and December 31, 2025, at $ 2,955,700 and $ 4,193,434 respectively. (1) As of January 21, 2026, the date of the reverse stock split (the reverse stock split), the Company has sufficient authorized shares available to settle certain outstanding warrants. As a result, these warrants met the criteria for equity classification and the corresponding embedded derivative no longer required separate liability classification. The carrying amount of the derivative liability of $ 1,513,786 as of that date was reclassified to additional paid-in capital. On January 21, 2026, the Company revalued all of the warrants associated with the convertible notes dated May 28, 2025, July 15, 2025, and September 24, 2025. The Company used the Monte Carlo simulation valuation method with the following assumptions as of January 21, 2026, risk free rate at 3.78 % to 3.80 %, and volatility of 194.76 % to 224.55 %, which resulted in a fair value of $ 1,513,786 , which was $ 98,012 less than the fair value at December 31, 2025. The Company reduced the derivative liability and a credited expense for $ 98,012 , for the three months ended March 31, 2026. (2) For the derivative liabilities associated with the embedded conversion feature of convertible notes, the Company used the Monte Carlo simulation valuation method with the following assumptions as of March 31, 2026, and December 31, 2025, risk free rate at 3.70 % to 3.72 %, and 3.54 % to 3.67 %, respectively, and volatility of 256.63 % to 350.37 %, and 300.23 % to 347 %, respectively. (3) For the derivative liabilities associated with the remaining outstanding warrants which were primarily issued in prior years, the following assumptions were utilized in the Black-Scholes valuation method as of March 31, 2026, and December 31, 2025, risk free interest rate of 3.71 % to 3.80 %, and 3.54 % to 3.59 %, respectively, volatility of 344.86 % and 347 %, respectively, and exercise prices of $ 1.00 to $ 40.00 post reverse split ($ 0.0002 to $ 0.008 prior to the reverse split) per share for both periods. A summary of the activity related to derivative liabilities for the three months ended March 31, 2026, and 2025, is as follows: SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE Derivative liabilities associated with warrants Derivative liabilities associated with convertible notes Total derivative liabilities Balance January 1, 2026 $ 1,644,738 $ 2,548,696 $ 4,193,434 Fair value of issuances - 245,779 245,779 Change in fair value ( 120,823 ) 151,096 30,273 Reclassified to equity ( 1,513,786 ) - ( 1,513,786 ) Balance March 31, 2026 $ 10,129 $ 2,945,571 $ 2,955,700 Derivative liabilities associated with warrants Derivative liabilities associated with convertible notes Total derivative liabilities Balance January 1, 2025 $ 176,103 $ 34,390 $ 210,493 Fair value of issuances - - - Change in fair value ( 118,783 ) 7,024 ( 111,759 ) Balance March 31, 2025 $ 57,320 $ 41,414 $ 98,734 F- 19 NOTE 6 – NOTES PAYABLE The Company has the following notes payable outstanding: SCHEDULE OF NOTES PAYABLE March 31, 2026 December 31, 2025 Note payable, interest at 8 % or 20 % (if default), matured January 5, 2020 , in default $ 45,000 $ 45,000 Other, due on demand, interest at 6 %, currently in default 50,000 50,000 Note payable $ 750,000 face value, interest at default rate of 24 %, matured August 24, 2021 , in default 375,000 375,000 Note payable $ 389,423 face value, interest at 15 %, matured November 6, 2025 , in default 389,423 389,423 Note payable $ 1,000,000 face value, interest 24 % default rate, matured November 13, 2021 , in default 1,000,000 1,000,000 Note payable $ 11,110,000 face value, interest at 15 %, matured October 31, 2024 , in default 11,110,000 11,110,000 Note payable $ 3,300,000 face value, interest at 15 %, matured October 31, 2024 , in default 3,300,000 3,300,000 Note payable $ 3,020,000 face value, matured March 31, 2023 , in default 1,820,000 1,820,000 Note payable $ 165,000 face value, interest at 15 %, matures August 13, 2026 , net of discount of $ 5,625 (2026) and $ 9,375 (2025), respectively 159,375 155,625 Note payable $ 250,000 face value, interest at 15 %, matures November 21, 2026 , net of discount of $ 34,375 (2026) and $ 46,875 (2025), respectively 215,625 203,125 Note payable $ 100,000 face value, interest at 15 %, matures January 5, 2027 , net of discount of $ 7,500 92,500 - Note payable $ 110,000 face value, interest at 15 %, matures February 3, 2027 , net of discount of $ 8,333 101,667 - Sub-total notes payable, net of discount 18,658,590 18,448,173 Less long-term portion, net of discount - - Current portion of notes payable, net of discount $ 18,658,590 $ 18,448,173 On January 5, 2026, the Company entered into a 15 % Secured Promissory Note for $ 100,000 with a third-party lender and a maturity date of January 5, 2027 . The Company received proceeds of $ 90,000 on January 5, 2026, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 10,000 (original issue discount or “OID”). This note shall be senior secured by any and all assets of the Company. For the three months ended March 31, 2026, $ 2,500 was charged to interest expense. As of March 31, 2026, the outstanding principal balance of this note was $ 100,000 with a carrying value of $ 92,500 , net of unamortized discounts of $ 7,500 as of March 31, 2026. On February 3, 2026, the Company entered into a 15 % Secured Promissory Note for $ 110,000 with a third-party lender and a maturity date of February 3, 2027 . The Company received proceeds of $ 100,000 on February 5, 2026, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 10,000 (original issue discount or “OID”). This note shall be senior secured by any and all assets of the Company. For the three months ended March 31, 2026, $ 1,667 was charged to interest expense. As of March 31, 2026, the outstanding principal balance of this note was $ 110,000 with a carrying value of $ 101,667 , net of unamortized discounts of $ 8,333 as of March 31, 2026. On November 21, 2025, the Company entered into a 15 % Secured Promissory Note for $ 250,000 with a third-party lender and a maturity date of November 21, 2026 . The Company received proceeds of $ 200,000 on December 9, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 50,000 (original issue discount or “OID”). This note shall be senior secured by any and all assets of the Company. For the three months ended March 31, 2026, $ 12,500 was charged to interest expense. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 250,000 with a carrying value of $ 215,625 , and $ 203,125 , respectively, net of unamortized discounts of $ 34,375 and $ 46,875 as of March 31, 2026, and December 31, 2025, respectively. F- 20 On August 13, 2025, the Company entered into a 15 % Secured Promissory Note for $ 165,000 with a third-party lender and a maturity date of August 13, 2026 . The Company received proceeds of $ 150,000 on August 14, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 15,000 (original issue discount or “OID”). This note shall be senior secured by any and all assets of the Company. For the three months ended March 31, 2026, $ 3,750 was charged to interest expense. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 165,000 with a carrying value of $ 159,375 and $ 155,625 , respectively, net of unamortized discounts of $ 5,625 and $ 9,375 as of March 31, 2026, and December 31, 2025, respectively. On November 11, 2022, the Company entered into a non-interest bearing, $ 3,020,000 face value promissory note with a third-party lender with scheduled weekly payments and a maturity date of March 31, 2023 . In exchange for the issuance of the $ 3,020,000 note, inclusive of an original issue discount of $ 250,000 , and the reclass of $ 260,000 from accounts payable and accrued expenses the Company received proceeds of $ 2,510,000 on November 11, 2022, from the lender. Through December 31, 2025, the Company has repaid $ 1,200,000 of the principal of the note. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was 1,820,000 . The Company is in default on the weekly payments. The Company is currently in discussions with the lender regarding an extension of the maturity date. On December 7, 2021, the Company entered into a 12 %, $ 3,300,000 face value promissory note with a third- party lender with a maturity date of December 7, 2022 . In exchange for the issuance of the $ 3,300,000 note, inclusive of an original issue discount of $ 300,000 , the Company received proceeds of $ 3,000,000 on December 13, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15 % per annum. The Company determined that this transaction was a modification of the existing note. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 3,300,000 . The Company is currently in discussions with the lender regarding an extension of the maturity date. On March 17, 2021, the Company entered into a 12 %, $ 11,110,000 face value promissory note with a third- party lender with a maturity date of March 17, 2022 . In exchange for the issuance of the $ 11,110,000 note, inclusive of an original issue discount of $ 1,000,000 and lender costs of $ 110,000 , the Company received proceeds of $ 10,000,000 on March 23, 2021, from the lender. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15 % per annum. The Company determined that this transaction was a modification of the existing note. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 11,110,000 . The Company is currently in discussions with the lender regarding an extension of the maturity date. On November 13, 2020, the Company entered into a 12 %, $ 1,000,000 face value promissory note with a third-party due November 13, 2021 . Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date. The Company received proceeds of $ 890,000 on November 20, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 110,000 . In conjunction with this note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 25,000 post reverse split ( 125,000,000 prior to the reverse split) shares of common stock at an exercise price of $ 40 post reverse split ($ 0.008 prior to the reverse split) per share, subject to adjustments and expires on the eight-year (as amended) anniversary of the issue date. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 1,000,000 . As of March 31, 2026, and December 31, 2025, the accrued interest is $ 1,155,452 and $ 1,095,452 , respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note. On November 6, 2020, the Company entered into a Settlement Agreement with the holder of $ 120,000 of convertible notes with accrued and unpaid interest of $ 8,716 and a $ 210,000 Promissory Noted dated June 23, 2020, with accrued and unpaid interest of $ 15,707 . The Company issued a new 12 % Promissory Note with a face value of $ 389,423 and a maturity date of November 6, 2023 , and was in default. In conjunction with this settlement, the Company issued a warrant to purchase 12,000 post reverse split ( 60,000,000 prior to the reverse split) shares of common stock at an exercise price of $ 37.50 post reverse split ($ 0.0075 prior to the reverse split) per share, subject to adjustments and expires on the five-year anniversary of the issue date. The Company analyzed the transaction and concluded that this was a modification to the existing debt. The investor exercised the warrant on January 14, 2021. On November 6, 2023, the maturity date of the note was extended to November 6, 2025, and the interest rate was increased to 15 % per annum. The Company issued warrants to purchase 12,000 post reverse split ( 60,000,000 prior to the reverse split) shares of common stock at an exercise price of $ 9.50 post reverse split ($ 0.0019 prior to the reverse split) per share, and with an expiration of November 6, 2026, in exchange for the extension. The warrants were valued at $ 113,921 by the Black-Scholes option pricing method and have been amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three months ended March 31, 2026, and 2025, $- 0 - and $ 14,240 , respectively, were charged to interest expense. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 389,423 . As of March 31, 2026, and December 31, 2025, the accrued interest is $ 283,940 and $ 269,331 , respectively. F- 21 On August 24, 2020 (the “Issue Date”), the Company entered into a 12 %, $ 750,000 face value promissory note with a third-party (the “Holder”) due August 24, 2021 (the “Maturity Date”). Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $ 663,000 on August 25, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 87,000 . In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 24,590 post reverse split ( 122,950,819 prior to the reverse split) shares of common stock at an exercise price of $ 30.50 post reverse split ($ 0.0061 prior to the reverse split) per share, subject to adjustments and expires on the five-year anniversary of the Issue Date. On July 15, 2025, the warrants were extended to have a maturity date of the eighth-year anniversary of the Issue Date. As of March 31, 2026, and December 31, 2025, the outstanding principal balance of this note was $ 375,000 . This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law . During the three months ended March 31, 2026, the Holder converted $ 21,742 of accrued interest (plus conversion fees) into 322,400 shares of common stock at a conversion price of $ .04624 to $ 0.0942 . As of March 31, 2026, and December 31, 2025, the accrued interest is $ 431,407 and $ 423,896 , respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note. NOTE 7 – DEFERRED LIABILITY On September 2, 2020, PCTI entered into an agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $ 750,000 , PCTI agreed to pay the third-party a perpetual three percent ( 3 %) payment of revenues, as defined in the agreement. Payments are due ninety (90) days after each calendar quarter, with the first payment due on or before March 31, 2021, for revenues for the quarter ending December 31, 2020. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the note was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8 %. No payments have been made and the Company is in default of the agreement. On November 11, 2022, the third-party and the Company agreed to reduce the liability by $ 260,000 and add $ 260,000 to the promissory note issued on November 11, 2022. EV Insurance Company records premiums received from the issuance of Vehicle Service Contracts (“VSC’s”) as a deferred liability. The Company will analyze the deferred liability to determine if any amounts can be recorded as income with the balance remaining in deferred liabilities for potential future claims. During the three months ended March 31, 2026, the Company paid a claim of $ 12,779 and charged the deferred liability account. As of March 31, 2026, and December 31, 2025, the Company has recorded $ 39,931 and $ 42,425 as deferred liabilities related to VSC’s. The deferred liability as of March 31, 2026, and December 31, 2025, on the consolidated balance sheets is $ 529,931 and $ 532,425 respectively. F- 22 NOTE 8 – RELATED PARTY TRANSACTIONS AND BALANCES Employment Agreement On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the “Employment Agreement”). Mr. Conway’s compensation as adjusted was $ 20,000 per month. Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway receives annual compensation of $ 240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company’s subsidiaries. Currently, the subsidiaries of Ozop Capital, OES and OED, each compensates Mr. Conway $ 20,000 per month. Management Fees, Sale of Building and Related Party Payables For the three months ended March 31, 2026, and 2025, the Company recorded expenses to Mr. Conway of $ 240,000 , respectively. During the year ended December 31, 2025, the Company sold its building to an entity controlled by Mr. Conway. The sale price was $ 600,000 and the Company received $ 100,000 in cash and Mr. Conway forgave $ 500,000 of related party accrued and unpaid management fees owed. After the building was sold to the related party, the Company leased back the building from the same related party in September 2025 for a three-year lease with a monthly lease payment of $ 5,000 beginning on September 1, 2026, which was accounted for as a sale and leaseback transaction (see Note 12). As of March 31, 2026, and December 31, 2025, the Company owes Mr. Conway $ 376,600 and $ 281,600 for unpaid management fees, which is included in related party liabilities on the unaudited consolidated balance sheets presented herein. Note receivable, related party During the year ended December 31, 2025, the Company loaned 14464664 Canada Inc. (“Bluezone Beverages”) $ 150,000 in exchange for a promissory note issued on December 9, 2025, that bears interest at 5 % and has a maturity date of December 8, 2027 . On January 5, 2026, and February 4, 2026, the Company loaned Bluezone Beverages $ 75,000 and $ 100,000 respectively. As of March 31, 2026, and December 31, 2025, the balances of note receivable, related party is $ 325,000 and $ 150,000 , respectively, and is included in non-current assets on the unaudited consolidated balance sheets. The Company has a binding letter of intent with Bluezone . NOTE 9 – COMMITMENTS AND CONTINGENCIES Agreements On September 1, 2021, Ozop Capital entered into an advisory agreement (the “RMA Agreement”) with Risk Management Advisors, Inc. (“RMA”). Pursuant to the terms of the RMA Agreement, RMA will assist Ozop Capital in analyzing, structuring, and coordinating Ozop Capital’s participation in a captive insurance company. RMA will coordinate legal, accounting, tax, actuarial and other services necessary to implement the Company’s participation in a captive insurance company, including, but not limited to, the preparation of an actuarial feasibility study, filing of all required regulatory applications, domicile selection, structural selection, and coordination of the preparation of legal documentation. The fee for these services was $ 100,000 . Ozop Capital agreed to pay $ 50,000 and to issue $ 50,000 of shares of restricted common stock. The parties agreed to a reduced fee of $ 48,000 for the years ended December 31, 2025. As of March 31, 2026, and December 31, 2025, $ 144,000 is included in accounts payable and accrued expenses on the unaudited consolidated balance sheets presented herein. As of March 31, 2026, and December 31, 2025, the Company has recorded 128 post reverse split ( 637,755 prior to the reverse split) shares of common stock to be issued for the balance owed, in addition to the $ 48,000 . On March 4, 2019, the Company entered into a Separation Agreement (the “Separation Agreement”) with Salman J. Chaudhry, pursuant to which the Company agreed to pay Mr. Chaudry $ 227,200 (the “Outstanding Fees”) in certain increments as set forth in the Separation Agreement. As of March 31, 2026, and December 31, 2025, the balance owed Mr. Chaudhry is $ 162,085 . On September 2, 2020, PCTI entered into an Agreement with a third-party. Pursuant to the terms of the agreement, in exchange for $ 750,000 , PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the agreement was amended, whereby in exchange for 35,000 post reverse split ( 175,000,000 prior to the reverse split) shares of common stock, the royalty percentage was amended to 1.8 % (see Note 7). As of March 31, 2026, and December 31, 2025, the Company has recorded $ 243,272 , respectively, and is included in accounts payable and accrued expenses on the unaudited consolidated balance sheets presented herein. F- 23 Legal matters We know of no material, existing or pending legal proceedings against our Company. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest. NOTE 10– STOCKHOLDERS’ EQUITY Reverse Stock Split On January 16, 2026, the Company filed a Certificate of Amendment to the Certificate of Incorporation of the Company with the Nevada Secretary of State to effect a reverse stock split at a 1-for-5,000 ratio. On January 21, 2026 (the “Effective Time”), every 5,000 shares of issued and outstanding Common Stock automatically combined into one issued share of common stock, with no change in par value. No fractional shares were issued as a result of the Reverse Stock Split. Instead of issuing fractional shares, the Company rounded shares up or down to the nearest whole number as determined by DTC at the participant level. The Reverse Stock Split did not modify any voting rights or other terms of the Common Stock. The Company’s Common Stock began trading on a reverse stock split-adjusted basis at the open of the markets on February 21, 2026. As a result, the number of shares of Common Stock outstanding was reduced from 13,327,772,635 shares to 2,665,555 shares, exclusive of 58,309 whole shares issued for rounding up fractional shares (which were issued in January 2026), and the number of authorized shares of Common Stock remains 25,990,000,000 shares. Common stock On January 22, 2026, DTC requested 58,309 shares of common stock as the result of rounding up shares for the reverse stock split. During the three months ended March 31, 2026, the Company issued an aggregate of 439,796 post reverse split shares of common stock and received net proceeds of $ 47,069 after issuance costs of $ 5,654 and $ 5,000 of accrued interest repayment. During the three months ended March 31, 2026, the Company issued 322,400 post reverse split shares of common stock in payment of accrued interest of $ 20,243 and fees of $ 1,500 . During the three months ended March 31, 2026, the Company issued 300,000 post reverse split shares of common stock pursuant to a Service Agreement with a third party and recorded stock based compensation of $ 48,000 . During the three months ended March 31, 2025, the Company issued an aggregate of recorded 226,766 post reverse split ( 1,133,822,555 prior to the reverse split) shares of common and received net proceeds of $ 260,805 after issuance costs of $ 10,552 . Increase in Authorized Shares On March 4, 2025, the Board of Directors of the Company approved to amend the Company’s Articles of Incorporation (the “March 2025 Amendment”) to increase the authorized capital stock of the Company to 16,000,000,000 shares, of which 15,990,000,000 shall be authorized as common shares and 10,000,000 shall be authorized as preferred shares. The Company filed the March 2025 Amendment with the State of Nevada on April 10, 2025. On May 21, 2025, the Board of Directors of the Company approved to amend the Company’s Articles of Incorporation (the “May 2025 Amendment”) to increase the authorized capital stock of the Company to 26,000,000,000 shares, of which 25,990,000,000 shall be authorized as common shares and 10,000,000 shall be authorized as preferred shares. The Company filed the May 2025 Amendment with the State of Nevada on July 1, 2025. Preferred stock As of March 31, 2026, and December 31, 2025, 10,000,000 shares have been authorized as preferred stock, par value $ 0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time. F- 24 Series C Preferred Stock On July 7, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote . As of March 31, 2026, and December 31, 2025, there were 2,500 shares of Series C Preferred Stock issued and outstanding and the shares are held by Mr. Conway. Series D Preferred Stock On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 18,667 shares of Series D preferred Stock to Chis, and on August 28, 2020, pursuant to Mr. Conway’s employment agreement, the Company issued 1,333 shares of Series D Preferred Stock to Mr. Conway. On July 13, 2021, the Company purchased 18,667 shares of the Company’s Series D Preferred Stock held by Chis. On July 27, 2021, the Company filed with the Secretary of State of the State of Nevada an Amended and Restated Certificate of Designation of Series D Preferred Stock (the “Series D Amendment”). Under the terms of the Series D Amendment, 4,570 shares of the Company’s preferred stock will be designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. Any holder may, at any time convert any number of shares of Series D Convertible Preferred Stock held by such holder into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 1.5 and dividing that number by the number of authorized shares of Series D Convertible Preferred Stock and multiply that result by the number of shares of Series D Convertible Preferred Stock being converted. Except as provided in the Series D Amendment or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 28, 2021, the Company closed on a Stock and Warrant Purchase Agreement (the “Series D SPA”). Pursuant to the terms of Series D SPA, an investor in exchange for $ 13,200,000 purchased one share of Series D Preferred Stock, and a warrant to acquire 3,236 shares of Series D Preferred Stock. As of March 31, 2026, and December 31, 2025, there were 1,334 shares, respectively, of Series D Preferred Stock issued and outstanding and a warrant to purchase 3,236 shares of Series D Preferred Stock are outstanding as of March 31, 2026, and December 31, 2025. The warrant has a 15 - year term and Partial Warrant Lock Up and Leak-Out Period. The Holder may only exercise the Warrant and purchase Warrant Shares as follows: i. Up to 162 (one hundred and sixty-two) Warrant Shares, at any time or times on or after five (5) business days from the closing of the Series D SPA (“the Initial Exercise Date”) subject to up to a maximum number of Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company and no later than on or before the 15 th year anniversary of the Initial Exercise Date (“the Termination Date”); and ii. The Remainder of the Warrant representing up to 3,074 (three thousand and seventy-four) Warrant Shares (“Remaining Warrant Shares”) shall be locked up for a period of 36 (thirty-six) months from the Initial Exercise Date (“Lock Up Period”) and shall become exercisable at any time or times from the date that is the 36 (thirty-six) month anniversary of the Initial Exercise Date (“Lock Up Period Termination Date”) and no later than on or before the Termination Date, as follows: a. During every 1 (one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year (“Leak-Out Period”). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034, and until the Termination Date. F- 25 Series E Preferred Stock On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company’s Series E Preferred Stock. Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company’s preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock (“Optional Redemption”) at $ 1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration. As of March 31, 2026, and December 31, 2025, there were - 0 - shares of Series E Preferred Stock issued and outstanding, respectively. NOTE 11 – NONCONTROLLING INTEREST On August 19, 2021, the Company formed Ozop Capital. The Company initially owned 51 % with PJN Holdings, LLC (“PJN”) owning 49 %. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. The Company presents interest held by noncontrolling interest holders within noncontrolling interest in the consolidated financial statements. On September 13, 2022, there was a change in the ownership percentages, as PJN returned 490,000 shares, representing their 49 % ownership. As of that date, Ozop Capital is a wholly owned subsidiary of the Company. As of March 31, 2026, and December 31, 2025, the accumulative noncontrolling interest is $ 784,777 , respectively. NOTE 12 - OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES On April 14, 2021, the Company entered into a 5 five-year lease which began on June 1, 2021, for approximately 8,100 square feet of office and warehouse space in Carlsbad, California, expiring May 31, 2026. Initial lease payments of $ 13,148 begin on June 1, 2021, and increase by approximately 2.4 % annually thereafter. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5 %, as the interest rate implicit in most of our leases is not readily determinable. During the year ended December 31, 2021, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $ 702,888 for this lease. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Sale-Leaseback Transaction In August 2025, the Company sold its building in Warwick, New York to a related party (see Note 4 and Note 8) with the related party obtained full control of the real property and no “continuing involvement” of the Company after the sale. On September 1, 2025, the Company entered into a three-year lease with the same related party to lease back the previously sold building for office space, expiring August 31, 2028. Lease payments of $ 5,000 begin on September 1, 2026, on a monthly basis. The Company determined that the sale and leaseback transaction qualified as a sale, and the sale and the leaseback were accounted for separately, with the lease being accounted for in accordance with ASC 842. This three-year lease agreement is determined to be an operating lease. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5 %, as the interest rate implicit in most of our leases is not readily determinable. During the year ended December 31, 2025, the Company recorded right-of-use assets and lease liabilities of $ 103,107 for this lease. In adopting Topic 842, the Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. F- 26 Right-of-use assets are summarized below: SCHEDULE OF RIGHT-OF-USE ASSETS March 31, 2026 December 31, 2025 Office and warehouse lease $ 805,995 $ 805,995 Less: Accumulated amortization ( 693,632 ) ( 644,318 ) Right-of-use assets, net $ 112,363 $ 161,677 Operating lease liabilities are summarized as follows: SCHEDULE OF OPERATING LEASE LIABILITIES March 31, 2026 December 31, 2025 Lease liability $ 137,040 $ 178,372 Less current portion ( 56,638 ) ( 84,644 ) Long term portion $ 80,402 $ 93,728 Maturity of lease liabilities are as follows: SCHEDULE OF MATURITY OF LEASE LIABILITIES For the year ending December 31, 2026 (remaining period) $ 49,612 For the year ending December 31, 2027 60,000 For the year ending December 31, 2028 40,000 Total $ 149,612 Less: present value discount ( 12,572 ) Lease liability $ 137,040 For the three months ended March 31, 2026, and 2025, the Company recorded a debit of $ 7,983 and a credit of $ 979 , respectively, to operating lease expense (after netting off the sublease income). NOTE 13 – DISCONTINUED OPERATIONS On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the unaudited accompanying consolidated financial statements for the three months ended March 31, 2025, and 2024. On October 3, 2022, PCTI filed a Voluntary Petition for Non- Individuals Filing for Bankruptcy. On November 30, 2022, the Trustee filed a Notice of Abandonment of Estate Property, as it is over encumbered by the secured creditors. No objections were filed, and as such the inventory and equipment is now considered abandoned to the secured creditors to do with what they wish. In March 2023, the Trustee declared this a no-asset case and closed the bankruptcy. There were no operating results from the discontinued operations for the three months ended March 31, 2026, and 2025.There are no assets as of March 31, 2026, and December 31, 2025, as the secured lender has taken possession. Liabilities of discontinued operations are separately reported as of March 31, 2026, and December 31, 2025. All liabilities are classified as current. The following tables present the reconciliation of carrying amounts of the major classes of liabilities of the Company classified as discontinued operations in the consolidated balance sheets at March 31, 2026, and December 31, 2025: Current liabilities SCHEDULE OF LOSS FROM DISCONTINUED OPERATIONS March 31, 2026 December 31, 2025 Accounts payable and accrued liabilities $ 445,565 $ 445,565 Current portion of notes payable 589,246 589,246 Total current liabilities of discontinued operations $ 1,034,811 $ 1,034,811 F- 27 On May 16, 2022, Huntington National Bank (“Huntington”) filed a Complaint for Confession of Judgment (“COJ”) against Catherine Chis (“Chis”). Chis was the former CEO of PCTI and a Guarantor on Huntington’s Letter of Credit financing (“LOC”) and a Term Loan (“Term Loan”). The Chis COJ for the LOC was for $ 352,415 and accrues per diem interest of $ 63.65 , and the Chis COJ for the Term Loan was for $ 141,415 and accrues per diem interest of $ 28.60 . On June 24, 2022, Huntington filed a COJ against Power Conversion Technologies, Inc (“PCTI”). The PCTI COJ for the LOC was for $ 354,774 and accrues per diem interest of $ 63.65 and the PCTI COJ for the LOC was for $ 142,473 and accrues per diem interest of $ 28.60 . On July 20, 2022, Huntington assigned the PCTI judgment against PCTI to Meraki Advisors, LLC. (“Meraki”). The Company’s understanding is Meraki is a Pennsylvania limited liability company, controlled by Chis. Included in the Current portion of notes payable are the principal balances of Huntington’s LOC of $ 344,166 and Term Loan of $ 134,681 . Accrued interest and fees on the LOC and Term Loan debt $ 54,256 is included in accounts payable and accrued liabilities. NOTE 14 - INCOME TAXES At the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods. Accordingly, the Company’s effective tax rate for the three months ended March 31, 2026, and 2025, was 0 % and 0 %, respectively. The Company’s effective tax rates for both periods were affected primarily by permanent differences between financial reporting and tax accounting for warrants, as well as a full valuation allowance on net deferred tax assets, based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company’s deferred tax assets as of March 31, 2026, and December 31, 2025. As of March 31, 2026, and December 31, 2025, the liability for uncertain tax positions is zero and the Company believes that no liability for unrecognized tax benefits is required in relation to the potential for additional assessments. NOTE 15 – SUBSEQUENT EVENTS Common Stock Issued for Conversions On April 14, 2026, the Holder of a convertible promissory note converted $ 12,950 of principal into 185,000 shares of common stock at a conversion price of $ 0.07 . On May 8, 2026, the Holder of the promissory note dated August 24, 2020, converted $ 23,023 of accrued interest and fees into 213,100 shares of common stock at a conversion price of $ 0.10804 . Common Stock Issued for Services On April 20, 2026, the Company issued 300,000 shares of restricted common stock, pursuant to an agreement for advisory services. Secured Promissory Note Issuance On May 13, 2026, the Company entered into a 15 % Secured Promissory Note for $ 110,000 with a third-party lender and a maturity date of May 13, 2027 . The Company received proceeds of $ 100,000 on May 13, 2026, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 10,000 . This note shall be senior secured by any and all assets of the Company. Convertible Promissory Note Issuance On May 14, 2026, the Company entered into a 12 %, $ 100,000 face value convertible promissory note with a third-party due February 28, 2027. The conversion price shall be equal to 65%, multiplied by the lowest trading price for the Common Stock during the ten (10) trading days prior to the conversion date. The Company received proceeds of $ 93,000 on May 15, 2026, and the Company reimbursed the investor for expenses for legal fees and due diligence of $ 7,000 . Pursuant to ASC 815, the Company determined that the conversion feature is embedded in the debt host and will account for the conversion feature as a derivative liability. The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein. F- 28 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying unaudited consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words “believes,” “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements. While our financial statements are presented on the basis that we are a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business over a reasonable length of time, our auditors have raised a substantial doubt about our ability to continue as a going concern. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results. Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates. The following discussion should be read in conjunction with our unaudited consolidated financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q. THE COMPANY Ozop Energy Solutions, Inc. (the “Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation (“Merger Sub”). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company’s name to “Ozop Energy Solutions, Inc.” That same day the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Merger Sub and filed Articles of Merger (the “Articles of Merger”) with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to “Ozop Energy Solutions, Inc.” On December 11, 2020, the Company formed On August 19, 2021, the Company formed Ozop Capital Partners, Inc. (“Ozop Capital”), a Delaware corporation and a wholly owned subsidiary of the Company. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. On October 29, 2021, EV Insurance Company, Inc. (“EVCO”) was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus. 3 On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. (“OED”) a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers. On June 11, 2024, the Company formed Automated Room Controls, Inc. (“ARC”) a Nevada corporation, as a wholly owned subsidiary of the Company. ARC was created to address a significant need in the lighting controls industry. ARC’s personnel has extensive experience in lighting controls since 2012, bringing together IT specialists and lighting control experts. We believe that easy deployment and creative applications can transform lighting controls into essential tools for enhancing the utility and ambiance of any space. The Company’s mission is to deliver cutting-edge technology that simplifies complex control needs, ensuring seamless integration and exceptional performance. OES operates in the renewable, electric vehicle (“EV”), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution. Equipment Distributor: In April 2021, the Company signed a five-year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the “Sublease”) with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company’s lease obligations through May 31, 2026, the lease termination date. Modular Energy Distribution System: The NeoVolt ™ System comprises the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. Our NeoVolt TM System offers (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint. The Company has developed a business plan for NeoVolt™, a scalable battery storage solution that aims to relieve the stress on existing grid infrastructure by providing distributed energy storage. With the first stage of engineered technical drawings completed, we are advancing to stage two and preparing to construct the initial prototype or proof of concept (PoC). NeoVolt™ is designed with advanced features, including automatic adoption of connected devices and dynamic load balancing through a master-slave configuration. These capabilities enable NeoVolt™ to seamlessly integrate with and manage energy flows across multiple devices. Furthermore, the PoC is contingent upon recent advancements in EV charging and discharging standardizations, including on-board inverters and bi-directional capabilities, to ensure compatibility and efficiency in both residential and commercial applications. OED specializes in lighting commissioning services. On September 27, 2024, OED signed an agreement with Leviton Manufacturing Co, Inc., to serve as a field service technician for their advanced lighting control systems. Ozop Plus markets vehicle service contracts (VSC’s”) for electric vehicles (EV’s) that offer consumers to be able to purchase additional months and miles above the manufacturer’s warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners’ concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus marketed VSC’s will give “peace of mind” to the EV buyer. On October 23, 2024, Ozop Capital Partners, Inc. entered into an agreement with Empire Auto Protect (“Empire”). Under the agreement, Empire will white label Royal Administration’s Fully Charged VSC, to be marketed as Empire Plus. OZOP Plus will be ceded the battery premium portion of all of the Empire Plus VSC’s contracted. 4 ARC has developed products to be an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. At its core, it employs a hybrid network topology that facilitates both resilient wired connections and flexible wireless communications, making it suitable for complex infrastructural environments. The system is equipped with an array of sensors and control nodes, enabling precise light management and energy usage monitoring. With support for protocols such as DALI and Zigbee, alongside the capability for seamless integration with IoT platforms, ARC offers a comprehensive solution for intricate lighting networks. This system is designed not just for control and efficiency, but also for adaptability to diverse architectural and electrical layouts, embodying a technical solution for advanced, energy-conscious lighting management. Discontinued Operations On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceedings which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three months ended March 31, 2026, and 2025. Results of Operations for the three months ended March 31, 2026, and 2025: Revenue For the three months ended March 31, 2026, the Company generated revenue of $56,053 compared to $42,257 for the three months ended March 31, 2025. Revenues from Ozop Energy Systems, Inc. (“OES”) and Automated Room Controls, Inc. (“ARC”) are classified as sourced and distributed products. Ozop Engineering and Design (“OED”) revenues are classified as design and installation. Sales are summarized as follows: Three months ended March 31, 2026 2025 Sourced and distributed products $ 315 $ 3,024 Design and installation 55,738 39,233 Total $ 56,053 $ 42,257 Design and installation revenues increased for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, as OED received more jobs in the current year period compared to the prior year quarter. Sales of sourced and distributed products (ARC and OES) were lower for the three months ended March 31, 2026, compared to the three months ended March 31, 2025. Cost of sales and Gross profit For the three months ended March 31, 2026, and 2025, the Company recognized $45,659 and $32,768, respectively, of cost of sales. Three months ended March 31, 2026 2025 Sourced and distributed products $ 2,385 $ 2,664 Design and installation 43,274 30,104 Total $ 45,659 $ 32,768 Three Months ended March 31, 2026 2025 Gross margin 18.5 % 22.4 % The gross margin on design and installation was 22.4% for the three months ended March 31, 2026, compared to 23.3% for the three months ended March 31, 2025. The Company recognized a gross margin on solar products (OES) of 11.9% for the three months ended March 31, 2025, and there were no sales and gross margin for the three months ended March 31, 2026. 5 Operating expenses Total operating expenses for the three months ended March 31, 2026, and 2025, were $671,802 and $940,318 respectively. The operating expenses were comprised of: Three months ended March 31, 2026 2025 Management fees, related parties $ 240,000 $ 240,000 Salaries, taxes and benefits 29,441 228,090 Stock compensation expense 48,000 - Travel expenses 1,683 23,399 Professional and consulting fees 223,815 229,175 Advertising and marketing 2,487 27,740 Building, rent and office expense 39,621 34,426 Research and development costs 142 24,668 Insurance 30,598 62,882 General and administrative, Other 56,015 69,938 Total $ 671,802 $ 940,318 Effective January 1, 2022, the Company entered into an employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway receives annual compensation of $240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company’s subsidiaries. Currently, the subsidiaries of Ozop Capital, OES and OED, each compensates Mr. Conway $20,000 per month. Salaries, taxes, and benefits decreased for the three months ended March 31, 2026, compared to March 31, 2025. OES currently has 1 employee with an aggregate annual salary of $72,000, compared to 2 employees with an aggregate annual salary of $204,000 for the three months ended March 31, 2025. The solar distribution of this vertical is being managed by our financial consultant and the Company’s CEO. For the three months ended March 31, 2026, OED was paying employees on a per hour basis for time travel to and from a job and time of service at a job and is 100% charged to cost of sales (see above). For the three months ended March 31, 2025, OED had two employees with an aggregate annual compensation of $244,000 and allocated $30,260 of salaries and payroll taxes to cost of sales for the three months ended March 31, 2025. ARC did not have any employees for the three months ended March 31, 2026, and is being managed by our financial consultant, our OES employee, and the Company’s CEO. For the three months ended March 31, 2025, ARC had 3 employees with an annual salary of $310,000. Ozop Capital Partners had one employee through January 15, 2026, with annual compensation of $144,000. The Company allocates salaries and related expenses to the appropriate subsidiary for where their services are being performed. The expenses per subsidiary included in operating expenses for the three months ended March 31, 2026, and 2025, are as follows: Three months ended March 31, 2026 2025 Ozop Energy Systems $ 23,018 $ 55,649 Ozop Engineering and Design - 56,385 Automated Room Controls, Inc. - 84,465 Ozop Capital Partners/EV Insurance Company 6,423 31,591 Total $ 29,441 $ 228,090 Stock based compensation of $48,000 during the three months ended March 31, 2026, related to the Company issuing 300,000 shares of common stock pursuant to a Service Agreement with a third party. The Company valued the shares at $0.16 per share. Travel expenses decreased for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, as the Company had lower travel expenses related to Systems and OED. Professional and consulting fees decreased slightly for the three months ended March 31, 2026, compared to the three months ended March 31, 2025. 6 Advertising and marketing expenses decreased for the three months ended March 31, 2026, compared to March 31, 2025, as result of the Company attending less trade shows in the current year compared to the prior year. Building, rent and office expense (including storage, supplies, utilities, and internet costs) increased for the three months ended March 31, 2026, compared to the three months ended March 31, 2025. Research and development costs decreased for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, due to the development and testing of the ARC products occurred in the 2025 period. Insurance expenses decreased for the three months ended March 31, 2026, compared to the three months ended March 31, 2025. The decrease was the result a decrease in health insurance related to the decrease in employees and the Company not renewing certain insurance policies for OES. The Company estimates that the monthly insurance expense to be approximately $12,000 per month. Other (Income) Expenses Other expense, net, for the three months ended March 31, 2026, was $1,822,305 compared to $626,342 for the three months ended March 31, 2025, and were as follows: Three months ended March 31, 2026 2025 Interest expense $ 1,792,032 $ 738,101 Gain (loss) on change in fair value of derivatives 30,273 (111,759 ) Total other expense, net $ 1,822,305 $ 626,342 The increase in interest expense for the three months ended March 31, 2026, is primarily a result of the amortization expense of $974,503 related to debt discounts on convertible notes payable and promissory notes payable compared to $14,240 for the three months ended March 31, 2025. For the three months ended March 31, 2026, the Company recognized a loss of $30,273, compared to the Company recognizing a gain of $111,759 for the three months ended March 31, 2025, on the change in the fair value of derivatives. Net loss Net loss attributable to the Company for the three months ended March 31, 2026, was $2,483,713, compared to $1,557,171 for the three months ended March 31, 2025. The change was primarily a result of the increase in other expenses, partially offset by the decrease in operating expenses. Liquidity and Capital Resources The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2026, the Company had an accumulated deficit of $236,064,897 and a working capital deficit of $40,724,721. As of March 31, 2026, the Company was in default of $18,714,423 plus accrued interest on debt instruments due to non-payment upon maturity dates or failure to comply with the loan’s contractual payment terms. Current cash balances are not sufficient to satisfy obligations currently due. Management is exploring capital raising options which may or may not become available on a timely basis to meet the obligations that are past due. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern. Currently, our current capital and our other existing resources will not be sufficient to provide the working capital needed for our current business, and additional capital will be required to meet our debt obligations, and to further expand our business. We may be unable to obtain the additional capital required on terms favorable to the Company or at all. If we are unable to generate capital or raise additional funds when required, it will have a negative impact on our business development and financial results. These conditions raise substantial doubt about our ability to continue as a going concern as well as our recurring losses from operations, deficit in equity, and the need to raise additional capital to fund operations. This “going concern” could impair our ability to finance our operations through the sale of debt or equity securities. Management’s plans in regard to these factors are discussed in Note 2 to the unaudited consolidated financial statements filed herein. 7 For the three months ended March 31, 2026, we primarily funded our business operations with the existing cash on hand as of January 1, 2026, cash received from collection of accounts receivable, $47,069 received from sales of common stock, $215,000 received from the issuance of convertible promissory notes of $222,000, and $190,000 received from the issuance of $210,000 promissory notes. As of March 31, 2026, we had cash of $83,779 as compared to $266,431 as of December 31, 2025. As of March 31, 2026, we had current liabilities of $40,993,623, compared to current assets of $268,902, which resulted in a working capital deficit of $40,724,721. The current liabilities are comprised of accounts payable and accrued expenses, related party liabilities, convertible debt, derivative liabilities, lease obligations, deferred liability, notes payable, and liabilities of discontinued operations. Operating Activities For the three months ended March 31, 2026, net cash used in operating activities was $459,721 compared to $724,822 for the three months ended March 31, 2025. For the three months ended March 31, 2026, our net cash used in operating activities was primarily attributable to the net loss of $2,483,713, adjusted the loss on the change in fair value of derivatives of $30,273, the non-cash items of interest expense of $1,006,782, amortization and depreciation of $52,539, and stock based compensation expense of $48,000. Net changes of $886,398 in operating assets and liabilities reduced the cash used in operating activities. For the three months ended March 31, 2025, our net cash used in operating activities was primarily attributable to the net loss of $1,557,171, the gain on the change in fair value of derivatives of $111,759, adjusted by non-cash items of interest expense of $14,241, and amortization and depreciation of $54,305. Net changes of $875,562 in operating assets and liabilities reduced the cash used in operating activities. Investing Activities For the three months ended March 31, 2026, the net cash used in investing activities was $175,000, resulting from loans to related party in exchange for promissory notes. For the three months ended March 31, 2025, the net cash used in investing activities was $3,490, primarily due to purchase of office and computer equipment. Financing Activities For the three months ended March 31, 2026, the net cash provided by financing activities was $452,069 of which $215,000 was net proceeds received from issuance of convertible notes, $47,069 from the sales of common stock to GHS, net of issuance costs, and $190,000 from the issuances of promissory notes payable. For the three months ended March 31, 2025, the net cash provided by financing activities was $260,805, from the sales of common stock to GHS, net of issuance costs. 8 Critical Accounting Policies and Estimates The Company’s unaudited consolidated financial statements are prepared in accordance with GAAP in the United States. The preparation of its consolidated financial statements and related disclosures requires it to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets and liabilities in the Company’s unaudited consolidated financial statements. The Company bases its estimates on historical experience, known trends and events and various other factors that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions. Our significant accounting policies are described in more details in Note 3 to our financial statements appearing in “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our most recent Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC on May14, 2026. While all these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. The SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Our management believes that given current facts and circumstances, there are no material estimates or assumptions with levels of subjectivity and judgement necessary to be considered critical accounting policies and estimates. There were no significant changes to our critical accounting policies and estimates during the three months ended March 31, 2026. OFF BALANCE SHEET ARRANGEMENTS We have no off-balance sheet arrangements, including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits. Item 3. Quantitative and Qualitative Disclosures about Market Risk. Not Applicable. Item 4. Controls and Procedures. Disclosure Controls and Procedures We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of March 31, 2026. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of March 31, 2026, the Company determined that there were control deficiencies that constituted material weaknesses, as described below. 1. We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities. 2. We did not maintain appropriate cash controls – As of March 31, 2026, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company’s bank accounts. Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls. 9 Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. Changes in Internal Controls over Financial Reporting There has been no change in our internal control over financial reporting during the three months ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. PART II. OTHER INFORMATION Item 1. LEGAL PROCEEDINGS There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest. Item 1A. RISK FACTORS Not applicable for smaller reporting companies. Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS On January 22, 2026, DTC requested 58,309 shares of common stock as the result of rounding up shares for the reverse stock split. On February 5, 2026, the Company issued 142,500 shares of common stock in payment of accrued interest of $12,674 and fees of $750. On March 2, 2026, the Company issued 300,000 shares of common stock pursuant to a Service Agreement with a third party and recorded stock based compensation of $48,000. On March 25, 2026, the Company issued 179,900 shares of common stock in payment of accrued interest of $7,569 and fees of $750. Item 3. DEFAULTS UPON SENIOR SECURITIES None Item 4. MINE SAFETY DISCLOSURE Not applicable. Item 5. OTHER INFORMATION (a) None. (b) During the quarter ended March 31, 2026, there have not been any material changes to the procedures by which security holders may recommend nominees to the Board of Directors. 10 Item 6. EXHIBITS The following documents are filed as part of this report: Exhibit No. Description 2.1 Share Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc. and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018). 2.2 Stock Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc. and Catherine Chis (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020). 2.3 Merger Agreement and Plan of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020). 3.1 Articles of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016) 3.2 Bylaws (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016) 3.3 Certificate of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018). 3.4 Certificate of Designations for Series B Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on April 2, 2019). 3.5 Amended and Restated Bylaws of Ozop Surgical Corp. adopted on May 22, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on May 22, 2019). 3.6 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019). 3.7 Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on September 24, 2019). 3.8 Certificate of Withdrawal of Series B Preferred Stock. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September 24, 2019). 3.9 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on October 31, 2019). 3.10 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019). 3.11 Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020). 3.12 Amended and Restated Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020). 3.13 Amendment to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 10, 2020). 11 3.14 Certificate of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on July 10, 2020). 3.15 Certificate of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed on July 10, 2020). 3.16 Articles of Incorporation of Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on November 13, 2020). 3.17 Articles of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on November 13, 2020). 3.18 Amended and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on August 2, 2021). 3.19 Advisory agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 2, 2021) 10.1 Binding Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp. and Power Conversion Technologies, Inc, and Catherine Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020). 10.2+ Employment Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Brian Conway, (Incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed on February 28, 2020). 31.1* Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63 101.INS* Inline XBRL Instance Document 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. + Management contract or compensatory plan or arrangement. 12 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: May 22, 2026 /s/ Brian P Conway Brian P. Conway Chief Executive Officer (principal executive officer) (principal financial and accounting officer) 13